In this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolving in the next 2-3 years and what big changes we can expect. Schoen also highlights the key challenges to creating a safe and secure supply chain that measures against counterfeiting and discusses the impact the Falsified Medicines Directive is having on the industry.
Boehringer Ingelheim's Johannes Schoen on the Evolution of Pharma Logistics
Pharma Logistics Editor | 02/22/2013